Business Context and Reporting Period
This Form 8-K Current Report was filed by Phreesia, Inc. on October 21, 2020, covering events occurring on October 19, 2020, and October 20, 2020. The filing announces the entry into a material definitive agreement for a public offering of common stock.
Key Financial Metrics and Transaction Details
- Shares Issued: 5,000,000 shares of Common Stock.
- Offering Price: $32.00 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 750,000 shares.
- Estimated Net Proceeds: Approximately $151.6 million (base offering) or approximately $174.4 million (if the over-allotment option is exercised in full), after deducting underwriting discounts and estimated offering expenses.
- Expected Closing Date: On or about October 23, 2020.
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this is a transactional report rather than a periodic financial statement.
Material Changes
The primary material change is the execution of an underwriting agreement with J.P. Morgan Securities LLC and William Blair & Company, L.L.C. This agreement facilitates the sale of new equity, which will significantly increase the company's cash position upon closing, subject to customary conditions.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance or management commentary regarding future operational performance. The transaction is subject to customary closing conditions. The Company is designated as an emerging growth company.
Key Facts for Investor Verification
- Verify the final closing date of the offering, currently expected to be October 23, 2020.
- Confirm whether the underwriters exercise the 30-day option to purchase the additional 750,000 shares.
- Review the final net proceeds after actual underwriting discounts and offering expenses are deducted.
- Check the updated share count and dilution impact post-closing.